Delmar Pharmaceuticals

Developer of drug candidates targeting orphan cancer indications

placeVancouver, British Columbia, Canada calendar_todayFounded 2010 groups3 employees language delmarpharma.com

Registered entities

Innovation

12 patent families (8 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 601 times.

YearFilings
20131
20151
20162
20175
20186
20193
20201
20211
20221
20232

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon